DUTASTERIDE CRISTERS 0,5 mg, capsule molle — plaquette(s) PVC polyéthylène PVDC aluminium de 30 capsule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930083567
  • CIP7 3008356
  • CIS 65166500

What the source publishes

Holder
CRISTERS
Active ingredients
DUTASTÉRIDE
Form
capsule molle
Package
plaquette(s) PVC polyéthylène PVDC aluminium de 30 capsule(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2017-01-30
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930083567
{
  "cis": "65166500",
  "cip7": "3008356",
  "form": "capsule molle",
  "name": "DUTASTERIDE CRISTERS 0,5 mg, capsule molle — plaquette(s) PVC polyéthylène PVDC aluminium de 30 capsule(s)",
  "cip13": "3400930083567",
  "holder": "CRISTERS",
  "routes": [
    "orale"
  ],
  "holders": [
    "CRISTERS"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "8.25",
  "authorisedOn": "2017-01-30",
  "compositions": [
    {
      "name": "DUTASTÉRIDE",
      "nature": "SA",
      "strength": "0,5 mg",
      "linkageNumber": "1",
      "substanceCode": "36065",
      "dosageReference": "une capsule",
      "pharmaceuticalElement": "capsule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "7.23",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "DUTASTERIDE CRISTERS 0,5 mg, capsule molle",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC polyéthylène PVDC aluminium de 30 capsule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2017-09-05",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DUTASTÉRIDE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Hypertrophie bénigne de la prostate, en seconde intention, après échec de certains autres traitements :<br>. traitement des symptômes modérés à sévères<br>. prévention des risques associés (rétention aiguë d'urine, chirurgie) ; JOURNAL OFFICIEL ; 22/02/13",
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930083567"